Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients.
Lavacchi D, Gelmini S, Calabri A, Rossi G, Simi L, Caliman E, Mancini I, Salvianti F, Petroni G, Guidolin A, Scolari F, Messerini L, Pillozzi S, Pinzani P, Antonuzzo L.
Lavacchi D, et al. Among authors: pillozzi s.
Heliyon. 2023 Nov 4;9(11):e21853. doi: 10.1016/j.heliyon.2023.e21853. eCollection 2023 Nov.
Heliyon. 2023.
PMID: 38027900
Free PMC article.